Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
Summary
This condition involves the use of sedative, hypnotic, or anxiolytic substances with an associated psychotic disorder characterized by hallucinations, induced by these substances. The pattern of use is not specified further, and the psychotic disorder is directly attributed to the effects of the sedative, hypnotic, or anxiolytic drugs. These substances are commonly prescribed for anxiety, insomnia, or sedation but may lead to psychotic symptoms, including hallucinations, in some individuals.
Causes
The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. The psychotic disorder with hallucinations is a direct result of the substance's effects on the central nervous system. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the induced psychotic disorder with hallucinations.
Risk Factors
- Prolonged or excessive use of these medications
- High dosages or frequent administration
- Personal or family history of substance use disorders
- Underlying mental health conditions (e.g., anxiety, depression)
- Easy access to sedative/hypnotic/anxiolytic drugs
- Recreational or non-medical use
Symptoms
- Use of sedative, hypnotic, or anxiolytic substances
- Hallucinations (auditory, visual, or other sensory)
- Psychotic symptoms directly linked to substance use
- Altered perception or reality testing
- Possible disorganized thinking or behavior
Diagnosis
Diagnosis is based on clinical evaluation of substance use history and assessment of psychotic symptoms, including hallucinations, that are directly attributable to the effects of sedative, hypnotic, or anxiolytic drugs. The unspecified nature of the use pattern indicates that criteria for a more specific disorder (e.g., abuse, dependence) are not met or documented.
Treatment Options
- Discontinuation or reduction of the causative substance under medical supervision
- Management of psychotic symptoms (e.g., antipsychotic medications)
- Supportive care to address withdrawal or intoxication effects
- Referral to mental health or substance use disorder specialists
- Monitoring for recurrence of symptoms
Prognosis and Follow-Up
Prognosis depends on the duration and severity of substance use, as well as the response to treatment. Early intervention and discontinuation of the causative substance may improve outcomes. Follow-up care is essential to monitor for relapse, manage residual symptoms, and address underlying substance use patterns.
Complications
- Worsening of psychotic symptoms
- Increased risk of self-harm or harm to others
- Substance use disorder development
- Cognitive impairment or memory issues
- Social or occupational dysfunction
Lifestyle & Prevention
- Avoid non-prescribed or excessive use of sedative/hypnotic/anxiolytic drugs
- Follow prescribed dosing instructions carefully
- Seek alternative treatments for anxiety or insomnia when possible
- Educate on risks of substance-induced psychosis
- Maintain open communication with healthcare providers about substance use
When to Seek Professional Help
Seek immediate medical attention if experiencing new or worsening hallucinations, severe confusion, or thoughts of self-harm. Contact a healthcare provider for persistent psychotic symptoms or concerns about substance use patterns.
Tips for Medical Coders
This code requires documentation of both sedative, hypnotic, or anxiolytic use (unspecified pattern) and a substance-induced psychotic disorder with hallucinations. Ensure clinical notes specify the presence of hallucinations and their direct link to the substance use. The unspecified use pattern indicates insufficient detail to classify the use as abuse, dependence, or another specific pattern.
Medical Policies and Guidelines
Related policies from health plans
F13.951 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.